Likes Subject
ONSS Did this every go through? MGC Pharmaceuticals The-REAL-KING-of-pennies 05/30/23 3:23 PM
yeah... you're correct, but will it be undervalued john1311 02/19/21 3:39 PM
Current market cap , around 215 m usd MADDSTACKER 02/18/21 9:40 AM
Still very undervalued MADDSTACKER 02/18/21 9:36 AM
up 37% in Australia today john1311 02/18/21 4:57 AM
This may be possible, they do stuff with syntax error 02/17/21 2:47 PM
Hey GW ... MADDSTACKER 02/17/21 8:47 AM
Shares in MGC Pharmaceuticals, an Australian medical cannabis john1311 02/17/21 3:39 AM
You may have something here. Great call greenwillow 02/17/21 1:10 AM
$1 a shares ... that would be nice... john1311 02/16/21 6:48 PM
Gw got picked up for billions ... market MADDSTACKER 02/10/21 3:12 PM
ASX-listed MGC Pharma is the first medical cannabis cbdstockswatcher 02/09/21 11:50 PM
I’m assuming this company will be bought ... MADDSTACKER 02/08/21 10:04 AM
- MGC Pharmaceuticals (MXC) has appointed Nicole Godresse cbdstockswatcher 02/08/21 4:45 AM
- MGC Pharmaceuticals (MXC) is set to become cbdstockswatcher 02/07/21 6:56 AM
nice move last couple of days congrats, hope hbhmb 02/02/21 6:54 PM
Australian daily volume can be seen on Yahoo morokoy 01/27/21 1:39 AM
Looks like profit taking from day before. Welcome to hbhmb 01/27/21 1:20 AM
Here’s hoping. Thanks so much hbhmb 01/27/21 1:17 AM
During the quarter, MGC Pharma completed the 100% morokoy 01/27/21 1:09 AM
https://stocknessmonster.com/announcements/mxc.asx-6A1016539/ Gives a link to morokoy 01/27/21 12:55 AM
thanks for the info , will see what happens? hbhmb 01/27/21 12:42 AM
With Shares Outstanding of 1,788,130,339 then 10MM morokoy 01/27/21 12:25 AM
been tracking this , any idea why the hbhmb 01/26/21 11:54 PM
MGC Pharma attracts $5m grant for its Malta-based morokoy 01/25/21 3:09 PM
MGC Pharmaceuticals confirms Phase II trial success for morokoy 01/25/21 3:08 PM
https://clinicaltrials.gov/ct2/show/NCT04382040?term=ArtemiC&draw=2&rank=1 Wow, Frankince morokoy 01/22/21 3:35 PM
https://www.proactiveinvestors.com.au/companies/news/933637/mgc-pharma--confident--following-complet morokoy 01/22/21 3:16 PM
$MGCLF Global Arena Holdings Subsidiary Global Election Services AskMuncher 10/12/20 5:54 AM
So, yeah, this huge here will go to Horsts 10/11/20 10:45 AM
Just got news they are Pink Current, realtmg 10/02/20 12:37 AM
$MGCLF Trading Halt AskMuncher 09/08/20 8:05 AM
Tranche 07/22/20 6:01 PM
Wondering what the benefits and effect of this WindFall_17 07/22/20 2:20 PM
$MGCLF-prosped has terms of a long squeeze propabally percents. WallStreetMyWay 07/22/20 11:14 AM
What will be the chances of getting off WindFall_17 06/08/20 10:31 AM
MGC Pharmaceuticals Ltd (ASX: MXC, ‘MGC’ or ‘the cbdstockswatcher 04/22/20 7:15 AM
Problem is the stock is trading in the cash4 04/19/20 12:55 AM
excellent news, thanks Cash4. john1311 04/17/20 3:30 PM
MGC Pharmaceuticals (ASX:MXC) receives Phase II trial approval cash4 04/17/20 7:58 AM
Tweet received. "Wait until you see the announcement JohnCM 03/25/20 9:35 AM
Cannepil now available in Ireland. Pretty big step rushmann 12/02/19 7:30 PM
Company is moving along and checking off boxes. rushmann 11/22/19 2:50 PM
"The Company has now passed the 1,000 prescribed cbdstockswatcher 11/03/19 10:07 PM
new ceo interview: https://www.wallstreetreporter.com/2019/05/mgc-pharmaceutical ThePez 06/06/19 4:26 PM
'MGC Lands Key Australian Cannabis Licence' cbdstockswatcher 05/29/19 5:28 AM
An EU-based BioPharma company, MGC Pharmaceuticals Ltd (ASX: Love3 05/10/19 8:07 PM
http://stockhead.com.au/health/epilepsy-and-dementia-sufferers-across-the-globe- londonohoyos 05/02/19 3:11 AM
Cannepil making it's debut in Aussieland and the rushmann 04/17/19 2:18 PM
The world-leading clinical trial, aimed at improving the Love3 04/08/19 12:36 AM
Likes Subject

The-REAL-KING-of-pennies
05/30/23 3:23 PM
MADDSTACKER
02/18/21 9:40 AM
MADDSTACKER
02/18/21 9:36 AM
john1311
02/18/21 4:57 AM
syntax error
02/17/21 2:47 PM
MADDSTACKER
02/17/21 8:47 AM
greenwillow
02/17/21 1:10 AM
john1311
02/16/21 6:48 PM
MADDSTACKER
02/10/21 3:12 PM
cbdstockswatcher
02/09/21 11:50 PM
MADDSTACKER
02/08/21 10:04 AM
cbdstockswatcher
02/07/21 6:56 AM
hbhmb
01/27/21 1:17 AM
hbhmb
01/26/21 11:54 PM
Horsts
10/11/20 10:45 AM
realtmg
10/02/20 12:37 AM
AskMuncher
09/08/20 8:05 AM
Tranche
07/22/20 6:01 PM
WindFall_17
07/22/20 2:20 PM
WindFall_17
06/08/20 10:31 AM
cbdstockswatcher
04/22/20 7:15 AM
cash4
04/19/20 12:55 AM
john1311
04/17/20 3:30 PM
cbdstockswatcher
11/03/19 10:07 PM
cbdstockswatcher
05/29/19 5:28 AM

MGC Pharmaceuticals (MGCLF)

Followers
20
Posters
46
Posts (Today)
0
Posts (Total)
1009
Created
11/02/17
Type
Free
Moderators
MGC Pharmaceutical
Web https://mgcpharma.com.au/

2018 INVESTOR PRESENTATION - A MUST READ
https://www.asx.com.au/asxpdf/20180515/pdf/43v17fngw661gw.pdf


3 DIVISIONS, MGC DERMA, MGC PHARMA, MGC BOTANIC
 
    Our three pioneering divisions allow MGC to be a key player in all significant levels of production in various global locations. It also allows MGC to progress with simultaneous high level research and development, clinical trials around the world and to embrace new emerging verticals in CBD markets.
 
ASX ANNOUNCEMENTS

MAY 2018 INVESTOR PRESENTATION      https://www.asx.com.au/asxpdf/20180515/pdf/43v17fngw661gw.pdf
MGC Gets Malta Deal 4/11/2018.                    https://www.asx.com.au/asxpdf/20180411/pdf/43t3r4swx14w98.pdf
 MGC LAUCHES NUTRACUTICAL LINE                                   https://www.asx.com.au/asxpdf/20180313/pdf/43scvsghl1fc2d.pdf
  MGC OPERATIONAL AND STRATEGY UPDATE                                  https://www.asx.com.au/asxpdf/20180305/pdf/43s586l6nvkppc.pdf
MGC HALF YEAR REPORT                                                     https://www.asx.com.au/asxpdf/20180226/pdf/43rx51n042y5dl.pdf
MGC LAUCHES ON CULT BEAUTY                                      https://www.asx.com.au/asxpdf/20180214/pdf/43rkmpx96lpj7d.pdf
MGC DECEMBER QUARTERLY REPORT                             https://www.asx.com.au/asxpdf/20180131/pdf/43r7dl2c3cv8lc.pdf
MGC INITIAL GMP CERTIFICATION                                   https://www.asx.com.au/asxpdf/20180125/pdf/43r1dqgtgcyhtx.pdf  
MGC LAUCHES PSORIASIS CREAM                                       https://www.asx.com.au/asxpdf/20180104/pdf/43qm6s1tzwb5pw.pdf
PURCHASE ORDER OF $40MIL VC DEAL REC'D                                   https://www.asx.com.au/asxpdf/20171114/pdf/43p6pqsf5jtgcc.pdf
MGC DERMA $40MIL DEAL EXECUTED                             https://www.asx.com.au/asxpdf/20171114/pdf/43p6pqsf5jtgcc.pdf
MGC BOTANICAL DIVISION UPDATE                                 https://www.asx.com.au/asxpdf/20171013/pdf/43n67fw0jy5j5l.pdf
MAJOR EUROPEAN PHARMA DEAL SIGNED                      https://www.asx.com.au/asxpdf/20171003/pdf/43mwyt2nty4zr4.pdf
MULTI MILLION AUSTRALIAN PHARMA DEAL                    https://www.asx.com.au/asxpdf/20171101/pdf/43nvx92qtdfjzm.pdf

Founded in 2014 by experts in the Medical Cannabis field with the intention of capitalising on the emerging global Medical Cannabis industry, founders Nativ Segev and Roby Zomer bring a combination of over 10 years in the Medical Cannabis and the BioTech industry. MGC Pharma was created to become a leading BioPharma company based on Medical Cannabis with operations spanning all aspects of the value chain, from cultivation, manufacturing and distribution of products in a global market.

Today, MGC Pharma has operations spanning Europe and Australia. It has cultivated and harvested crops in its growing facilities in the Czech Republic and Slovenia and is manufacturing active pharmaceutical ingredients (APIs) at its European GMP extraction facility. The Company has also developed a CBD cosmetics range that is available for purchase throughout Europe and online via the Company’s eShop www.mgcderma.com

MGC Botanic

The Botanic Division engages with multiple cultivation sites to meet increasing global demand, alongside research into breeding and genetics with leading institutions and academia. We will continue to harvest the product in Slovenia and Czech Republic, and use the raw material at our production facility, as well as provide the product globally.

Our research & development:

  • We’re excited to embark on a University of Ljubljana botanic research to develop new genetic strains.
    Refining and steadying MGC Pharma’s genetic bank to balance indications and treatment, and to guarantee our ability to produce flawless, high quality products all over the globe.  
    We’ve partnered with Academy of Science, Czech Republic, on numerous strain grows.
MGC Innovation

The Innovation Division is focused on our medical product pipeline and is our largest division. This division focuses on products that emerge from our supply line. These include neutraceuticals, which will be able to provide the additional needs and requirements that our body demands on a daily basis to improve our immune system, detoxify and enhance wellness.

Additionally, this includes our extracts, at various levels of purity, and with the ability to extract various phytocannabinoids and terpenes to the level of Active Pharmaceutical Ingredient.

The Innovation division is  focused on three specific areas of treatment:

  • Neurological disorders, which includes MGC Pharma’s proprietary formulations for Epilepsy
    Oncological care and treatment
    Autoimmune diseases, via taking advantage of the various anti-inflammatory benefits our products have on the body.
MGC Derma is our skincare and anti-aging line for day-to-day use. We are currently working on a new line of dermatological products called DermaPlus, which is already presenting impressive results from clinical studies. MGC Derma is a pioneering CBD cosmetic brand with distribution deals signed in various markets, presently in deliberations to engage in new markets.

MGC Derma produces CBD enhanced cosmetics, DermaPlus dermatological line and private label manufacturing.

Our research & development:

  • Derma Plus product range clinical tests finalized with the three products showing strong improvement in the skin conditions tests.
    Launch of product line in UK, Australia and USA planned for 2018.
 
Our three pioneering divisions allow MGC to be a key player in all significant levels of production in various global locations. It also allows MGC to progress with simultaneous high level research and development, clinical trials around the world and to embrace new emerging verticals in CBD markets.
 
MGC DERMA FEATURED ON CULT BEAUTY     https://www.cultbeauty.co.uk/mgc-derma

  •  
 

MGC Derma

MGC Derma is the brand leading the way in utilising this year’s ‘it’ skin care ingredient: cannabis. Before you get the wrong end of the stick… we’re talking about cannabidiol (CBD) a totally non-psychoactive compound derived from the cannabis plant, which shares part of the ‘fingerprint’ of our genetics, allowing the body to instantly recognise it – and utilise it accordingly. It is MGC Derma’s unique, meticulous extraction and purification process that keeps this ‘fingerprint’ intact; the brand uses only the highest quality cannabidiol in this range of pure yet potent serums, masks, toners and cream. Renowned for its healing, sebum-regulating and moisturising capabilities, CBD is particularly adept at addressing eczema, acne and other problematic skin conditions, as well as minimising signs of ageing, hydrating and nourishing.  

 
 
 

MGC Derma

MGC Derma is the brand leading the way in utilising this year’s ‘it’ skin care ingredient: cannabis. Before you get the wrong end of the stick… we’re talking about cannabidiol (CBD) a totally non-psychoactive compound derived from the cannabis plant, which shares part of the ‘fingerprint’ of our genetics, allowing the body to instantly recognise it – and utilise it accordingly. It is MGC Derma’s unique, meticulous extraction and purification process that keeps this ‘fingerprint’ intact; the brand uses only the highest quality cannabidiol in this range of pure yet potent serums, masks, toners and cream. Renowned for its healing, sebum-regulating and moisturising capabilities, CBD is particularly adept at addressing eczema, acne and other problematic skin conditions, as well as minimising signs of ageing, hydrating and nourishing.  

Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
MGCLF Latest News
  • No Recent News Available for this company!
Most Liked Posts
(Last 30 Days)
New Post